Recall Radar
All recallsMedicine & devices

Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN…

Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

Class III Medicine & devices FDA July 29, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Ascend Laboratories, LLC — Bedminster, NJ
Severity
Class III — low
Reported
July 29, 2026
Quantity
2,717 cartons
Recall number
D-0736-2026
Status
Ongoing
Source
FDA

Where it went

USA Nationwide

Other medicine & devices recalls

See every current recall on the live dashboard →